This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Omari, A. Articles by Twigg, S. M Search for Related Content Social Bookmarking                         What's this?

Exercise, metformin and hypoglycaemia: a neglected entity

Diabetes Centre and Department of Endocrinology, Royal Prince Alfred Hospital, Missenden Road, Camperdown NSW 2005, Australia

Dennis K Yue

Diabetes Centre and Department of Endocrinology, Royal Prince Alfred Hospital, Missenden Road, Camperdown NSW 2005, Australia, Discipline of Medicine, University of Sydney, NSW 2006, Australia

Stephen M Twigg

Diabetes Centre and Department of Endocrinology, Royal Prince Alfred Hospital, Missenden Road, Camperdown NSW 2005, Australia, stwigg{at}med.usyd.edu.au, Discipline of Medicine, University of Sydney, NSW 2006, Australia

We describe a case of hypoglycaemia induced by exercise in a patient with type 2 diabetes taking metformin, who was not taking insulin or sulphonylurea medication. The hypoglycaemia resolved after the dosage of metformin was reduced, despite increased physical activity. A brief review of the literature identifying the frequency of and risk factors for hypoglycaemia during treatment with metformin is discussed.

References

• Bailey CJ, Turner RC Metformin. N Engl J Med 1996;334:574-9.[Free Full Text]
• UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Fruehwald-Schultes B., Kern W., Oltmanns KM et al. Metformin does not adversely affect hormonal and symptomatic responses to recurrent hypoglycemia. J Clin Endocrinol Metab 2001;86:4187-92.[Abstract/Free Full Text]
• Knowler WC, Barrett-Connor E., Fowler SE et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.[Abstract/Free Full Text]
• Campbell RK, White JR Jr, Saulie BA Metformin: a new oral biguanide. Clin Ther 1996;18:360-71.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wiernsperger NF, Bailey CJ The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs 1999;58(suppl 1):31-9.[CrossRef]
• UK Prospective Diabetes Study (UKPDS) Group. United Kingdom Prospective Diabetes Study (UKPDS) 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 1995;310:83-8.[Abstract/Free Full Text]
• Zitzmann S., Reimann IR, Schmechel H. Severe hypoglycemia in an elderly patient treated with metformin. Int J Clin Pharmacol Ther 2002;40: 108-10.[Web of Science][Medline] [Order article via Infotrieve]
• UK Prospective Diabetes Study (UKPDS) Group. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995;44:1249-58.[Abstract]
• UK Prospective Diabetes Study (UKPDS) Group. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med 1998;128:165-75.[Abstract/Free Full Text]
• Radziuk J., Bailey CJ, Wiernsperger NF, Yudkin JS Metformin and its liver targets in the treatment of type 2 diabetes. Curr Drug Targets Immune Endocr Metabol Disord 2003;3:151-69.[CrossRef][Medline] [Order article via Infotrieve]
• Zou MH, Kirkpatrick SS, Davis BJ et al. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo: Role of mitochondrial reactive nitrogen species. J Biol Chem 2004;279:43940-51.[Abstract/Free Full Text]
• Ferriere M., Lachkar H., Richard JL, Bringer J., Orsetti A., Mirouze J. Captopril and insulin sensitivity. Ann Intern Med 1985;102:134-5.[Abstract/Free Full Text]
• Herings RM, de Boer A., Stricker BH, RLeufkens HG, Porsius A. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme.[see comment]. Lancet 1995;345:1195-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• White JR Jr, Hartman J., Campbell RK Drug interactions in diabetic patients. The risk of losing glycemic control. Postgrad Med 1993;93:131-2.[Medline] [Order article via Infotrieve]
• Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med 1997;103:491-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cryer PE Hypoglycemia is the limiting factor in the management of diabetes. Diabetes Metab Res Rev 1999;15:42-6.[CrossRef][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 2, 106-108 (2005)
DOI: 10.1177/14746514050050021001


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Omari, A. Articles by Twigg, S. M Search for Related Content Social Bookmarking                         What's this?